Oak Therapeutics, Inc

Oak Therapeutics, Inc., based in Lawrence, KS, is a patient-centric company dedicated to enhancing the administration of pharmaceuticals, particularly for those with difficulties such as children and individuals with dysphagia. Their innovative Oral Dissolvable Strips (ODS) aim to address the challenges faced by patients in both high-need countries and low-resource settings, focusing on improving access to essential medications like antibiotics and antivirals for infectious diseases.

Led by a team of experienced professionals, including CEO Ed Maliski and global strategist Gerhard Apfelthaler, Oak Therapeutics leverages proprietary computational models to optimize drug formulations and shorten development times. Their advisory board comprises experts from various fields, ensuring a comprehensive approach to tackling the complexities of pharmaceutical delivery and patient care.

Generated from the website